e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Mechanisms of lung injury: COPD, asthma and acute lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients
S. Huang, X. Guan (Guangzhou, China)
Source:
Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Session:
Mechanisms of lung injury: COPD, asthma and acute lung injury
Session type:
Thematic Poster Session
Number:
3640
Disease area:
Interstitial lung diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Huang, X. Guan (Guangzhou, China). Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients. Eur Respir J 2009; 34: Suppl. 53, 3640
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome
Source: Annual Congress 2007 - Lung recruitment
Year: 2007
Exogenous surfactant in acute respiratory distress syndrome: more is better
Source: Eur Respir J 2002; 19: 787-789
Year: 2002
Surfactant metabolism and replacement in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=119
Year: 2002
Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome
Source: Eur Respir J 2003; 21: 720-727
Year: 2003
Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: effects of corticosteroid
Source: Eur Respir J 2002; 20: Suppl. 38, 36s
Year: 2002
Surfactant therapy in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir Mon 2012; 55: 54-64
Year: 2012
NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded)
Source: Eur Respir Mon; 2008: 41: 60–71
Year: 2008
Effects of surfactant treatment on pulmonary outcome of near-term infants undergoing non invasive ventilation for idiopathic respiratory distress syndrome (IRDS)
Source: Annual Congress 2009 - Neonatal respiratory disorders
Year: 2009
Corticosteroids in acute respiratory distress syndrome
Source: Virtual Congress 2021 – Respiratory critical care
Year: 2021
Current invasive ventilatory strategies in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161
Year: 2002
Noninvasive ventilation in acute lung injury and acute respiratory distress syndrome
Source: Annual Congress 2009 - Controversies of noninvasive ventilation in acute patients
Year: 2009
KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome
Source: Eur Respir J 2004; 23: 142-145
Year: 2004
Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
The impact of two partial ventilatory support modalities on lung histology and inflammatory mediators in a model of acute respiratory distress syndrome
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007
Acute respiratory failure during pregnancy
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=241
Year: 2006
Corticosteroids and acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22
Year: 2002
Pulmonary gas-exchange impairments in pulmonary diseases: mechanisms
Source: Annual Congress 2007 - PG2 - Respiratory physiology: pulmonary gas transfer and arterial blood gases
Year: 2007
Pneumonectomy subjects with acute respiratory distress syndrome: what to do
Source: Eur Respir Rev 2015; 24: 154
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept